Julia C Tchou
Overview
Explore the profile of Julia C Tchou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
319
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Soegaard Ballester J, Goodsell K, Ermer J, Karakousis G, Miura J, Saur N, et al.
Ann Surg Oncol
. 2021 Sep;
29(3):1797-1804.
PMID: 34523005
Background: The American College of Surgeons Commission on Cancer's (CoC) new operative standards for breast cancer, melanoma, and colon cancer surgeries will require that surgeons provide synoptic documentation of essential...
12.
Burkbauer L, Goldbach M, Tchou J
Ann Surg Oncol
. 2021 Jul;
28(13):8663-8664.
PMID: 34304315
No abstract available.
13.
Hoffman D, Santos P, Tchou J
Ann Surg Oncol
. 2021 Jul;
28(13):8802-8803.
PMID: 34272615
No abstract available.
14.
Hoffman D, Santos P, Goldbach M, Keele L, Taunk N, Bogen H, et al.
Ann Surg Oncol
. 2021 Jul;
28(13):8789-8801.
PMID: 34269937
Introduction: National guidelines specify against immediate breast reconstruction (IBR) among inflammatory breast cancer (IBC) patients. However, limited data exist regarding this practice. We report practice patterns and oncologic outcomes among...
15.
Goldbach M, Burkbauer L, Bharani T, Williams A, Keele L, Rothman J, et al.
Ann Surg Oncol
. 2021 Jul;
28(Suppl 3):888.
PMID: 34264410
No abstract available.
16.
Ehret C, Zhou S, Tchou J, Schmitz K, Sturgeon K
Cancer Rep (Hoboken)
. 2021 Jul;
5(5):e1497.
PMID: 34240819
Background: Excess adiposity and dysregulated metabolism are associated with increased cancer risk. Triglycerides, cholesterol, glucose, insulin, HOMA-IR, and VO max are robust clinical-metabolic biomarkers of overall health. Aims: Aerobic exercise...
17.
Goldbach M, Burkbauer L, Bharani T, Williams A, Keele L, Rothman J, et al.
Ann Surg Oncol
. 2021 Jun;
28(13):8651-8662.
PMID: 34125350
Background: National medical/surgical organizations have recommended the use of neoadjuvant endocrine therapy (NET) to bridge surgery delay of weeks to months for patients with hormone receptor positive (HR+) breast cancer...
18.
Williams A, McGreevy C, Tchou J, De La Cruz L
Ann Surg Oncol
. 2020 May;
27(10):3605-3611.
PMID: 32472417
Background: Use of the Oncotype DX recurrence score (RS) has been widely adopted in women with early-stage hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER-) breast cancer (BC)....
19.
Li Y, Ro V, Tchou J
Curr Surg Rep
. 2019 Jul;
6(3).
PMID: 31293823
Obesity contributes to an estimated forty-percent, or 630,000 cases, of malignant neoplasms diagnosed in the United States[1] and higher body mass index (BMI) has been associated with at least seventeen...
20.
Pomponio M, Keele L, Fox K, Clark A, Matro J, Shulman L, et al.
Breast Cancer Res Treat
. 2019 May;
177(1):137-143.
PMID: 31119565
Purpose: A recent study reported that time to adjuvant chemotherapy (TTC) > 30 days was significantly associated with worse OS and DFS in triple-negative breast cancer (TNBC). Earlier studies, however,...